Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21005 | 376 | 35.8 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
668 | 12550 | NASOPHARYNGEAL CARCINOMA//EPSTEIN BARR VIRUS//EBV |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SLAM ASSOCIATED PROTEIN SAP | Author keyword | 2 | 67% | 1% | 2 |
2 | ANTI CMV ANTIBODIES | Author keyword | 1 | 50% | 1% | 2 |
3 | VARICELLA ARTHRITIS | Author keyword | 1 | 100% | 1% | 2 |
4 | ABORATING DEV HISTOPATHOL CLASSIFICAT D | Address | 1 | 50% | 0% | 1 |
5 | ANTI VZV ANTIBODIES | Author keyword | 1 | 50% | 0% | 1 |
6 | BRIGHAM WOMENS HOSP RHEUMATOL IMMUNOL ALL | Address | 1 | 50% | 0% | 1 |
7 | CD8MEMORY T CELLS | Author keyword | 1 | 50% | 0% | 1 |
8 | EBV NUCLEAR ANTIGEN 1 EBNA 1 | Author keyword | 1 | 50% | 0% | 1 |
9 | EPSTEIN BARR VIRUS LOAD | Author keyword | 1 | 50% | 0% | 1 |
10 | HUVS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SLAM ASSOCIATED PROTEIN SAP | 2 | 67% | 1% | 2 | Search SLAM+ASSOCIATED+PROTEIN+SAP | Search SLAM+ASSOCIATED+PROTEIN+SAP |
2 | ANTI CMV ANTIBODIES | 1 | 50% | 1% | 2 | Search ANTI+CMV+ANTIBODIES | Search ANTI+CMV+ANTIBODIES |
3 | VARICELLA ARTHRITIS | 1 | 100% | 1% | 2 | Search VARICELLA+ARTHRITIS | Search VARICELLA+ARTHRITIS |
4 | ANTI VZV ANTIBODIES | 1 | 50% | 0% | 1 | Search ANTI+VZV+ANTIBODIES | Search ANTI+VZV+ANTIBODIES |
5 | CD8MEMORY T CELLS | 1 | 50% | 0% | 1 | Search CD8MEMORY+T+CELLS | Search CD8MEMORY+T+CELLS |
6 | EBV NUCLEAR ANTIGEN 1 EBNA 1 | 1 | 50% | 0% | 1 | Search EBV+NUCLEAR+ANTIGEN+1+EBNA+1 | Search EBV+NUCLEAR+ANTIGEN+1+EBNA+1 |
7 | EPSTEIN BARR VIRUS LOAD | 1 | 50% | 0% | 1 | Search EPSTEIN+BARR+VIRUS+LOAD | Search EPSTEIN+BARR+VIRUS+LOAD |
8 | HUVS | 1 | 50% | 0% | 1 | Search HUVS | Search HUVS |
9 | SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE SLAM | 1 | 50% | 0% | 1 | Search SIGNALING+LYMPHOCYTIC+ACTIVATION+MOLECULE+SLAM | Search SIGNALING+LYMPHOCYTIC+ACTIVATION+MOLECULE+SLAM |
10 | SM B | 1 | 50% | 0% | 1 | Search SM+B | Search SM+B |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GLYCOPROTEIN GP110 | 12 | 75% | 2% | 9 |
2 | SM B B | 5 | 54% | 2% | 7 |
3 | HUMORAL AUTOIMMUNITY | 3 | 26% | 3% | 10 |
4 | EBNA I | 3 | 50% | 1% | 4 |
5 | ALANINE REPEATING REGION | 2 | 50% | 1% | 3 |
6 | ALTERED IMMUNE RESPONSE | 2 | 36% | 1% | 4 |
7 | INDUCED AUTOIMMUNE RESPONSES | 2 | 36% | 1% | 4 |
8 | PEPTIDE IMMUNIZATION | 2 | 17% | 2% | 8 |
9 | ARTHRITIS NUCLEAR ANTIGEN | 1 | 100% | 1% | 2 |
10 | HRES 1 ENDOGENOUS RETROVIRUS | 1 | 40% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus | 2014 | 11 | 35 | 51% |
Lupus and Epstein-Barr | 2012 | 27 | 39 | 44% |
Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: An update | 2007 | 41 | 57 | 58% |
The cryptic interplay between systemic lupus erythematosus and infections | 2014 | 14 | 74 | 23% |
Cytomegalovirus infection in patients with systemic lupus erythematosus | 2002 | 51 | 29 | 34% |
Epstein-Barr virus and systemic lupus erythematosus | 2006 | 44 | 48 | 42% |
Varicella Arthritis in Childhood A Case Report and Review of the Literature | 2011 | 0 | 14 | 86% |
Autoimmune disease: A role for new anti-viral therapies? | 2011 | 33 | 97 | 20% |
Epstein-Barr virus etiology in rheumatoid synovitis | 2005 | 19 | 24 | 67% |
Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis-Association and Causation | 2012 | 18 | 200 | 24% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ABORATING DEV HISTOPATHOL CLASSIFICAT D | 1 | 50% | 0.3% | 1 |
2 | BRIGHAM WOMENS HOSP RHEUMATOL IMMUNOL ALL | 1 | 50% | 0.3% | 1 |
3 | INSERM U639 | 1 | 50% | 0.3% | 1 |
4 | PATHOLVET ADM MED | 1 | 50% | 0.3% | 1 |
5 | HM MARSEILLE | 1 | 25% | 0.5% | 2 |
6 | U639 | 1 | 25% | 0.5% | 2 |
7 | INTERNAL MED B AUTOIMMUNE DIS | 0 | 33% | 0.3% | 1 |
8 | LAURA WATZ KIPP CHAIR AUTOIMMUN | 0 | 33% | 0.3% | 1 |
9 | RHEUMATOLIMMUNOL ALLERGY MED | 0 | 33% | 0.3% | 1 |
10 | AUTOIMMUNOL BIOMARKERS | 0 | 25% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000201170 | AUSTRALIAN VACCINE DEV TUMOUR IMMUNOL//EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1//JOINT ONCOL PROGRAM |
2 | 0.0000153429 | CRA DIP//SECC INMUNOGENET//SERV ATENDIMENTO ESPECIALIZADO SMS BELFORD ROXO |
3 | 0.0000122441 | INFECTIOUS MONONUCLEOSIS//MONONUCLEOSIS//ACUTE EBV INFECTION |
4 | 0.0000106278 | IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS//RADIATION THERAPY COMPLICATIONS//STANDARDIZED INCIDENCE RATE |
5 | 0.0000103913 | CHAIR PEDIAT CARDIOL 2//SYNOVIAL MEMBRANES//CLIN GRP 3 |
6 | 0.0000102574 | MIXED CONNECTIVE TISSUE DISEASE//LA SS B//RO SS A |
7 | 0.0000100269 | SCAPULOCOSTAL SYNDROME//CABRINI HOSP PUBL HLTH PREVENT MED//HOSP NORWAY IMMUNOL RHEUMATOL |
8 | 0.0000081677 | LMP1//LATENT MEMBRANE PROTEIN 1//EBV |
9 | 0.0000071105 | KRISTIAN GERHARD JEBSEN MS//MULTIPLE SCLEROSIS EPIDEMIOLOGY//NORWEGIAN MULTIPLE SCLEROSIS COMPETENCE |
10 | 0.0000067229 | CD4CD28 T CELLS//CD4CD28NULL T CELLS//CD4CD28NULL CELLS |